Belgian neurotechnology startup ReVision Implant has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its…
Read More
OncoRes Medical Closes A$27 Million Private Round To Advance Elora QME Imaging System And U.S. FDA Pathway
OncoRes Medical has closed an AUD $27 million private funding round to advance clinical development and regulatory milestones for its…
Read More
Mounjaro pediatric EU nod, FDA orforglipron quick-track scrutiny, and what to watch next
Eli Lilly and Company shares concludeed Friday, Dec. 12, 2025 higher — and held roughly steady in after-hours trading —…
Read More
Arexvy EU Expansion, Blujepa FDA Approval, Analyst Forecasts and What’s Next
Published: 12 December 2025 GSK plc stock is back in focus on Friday as investors digest a quick-relocating cluster of…
Read More
Gene Therapy Breakthrough, FDA Setback, and What’s Next for QURE Stock
Company & Focus: UniQure N.V. is a Dutch-American biotechnology company (NASDAQ: QURE) specializing in gene therapies. It developed the first…
Read More
Mesoblast CEO Silviu Itescu reflects on FDA setbacks and commercial success of Ryoncil
Oct 18, 2025 – 5.00am Gift this article Subscribe to gift this article Gift 5 articles to anyone you choose…
Read More
Strategic FDA Submissions and iCMR Innovation Position the Company for Market Breakthroughs
Imricor Medical Systems has emerged as a pivotal player in the MRI-guided ablation space, leveraging strategic regulatory submissions and groundbreaking…
Read More
Aktiia obtains FDA clearance for OTC cuffless blood pressure monitor
Healthcare technology company Aktiia has received FDA 510(k) clearance for its over-the-counter cuffless blood pressure monitor, G0 Blood Pressure Monitoring…
Read More
